Zhou Ye-Na, Xia Ji-Kai, Shi Chun-Ru, He Yan, Shang Shun-Lai
School of Medicine, Nankai University, Tianjin, 300071, China.
The College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Curr Med Sci. 2025 Jun 11. doi: 10.1007/s11596-025-00068-6.
Th17 cell-mediated immune injury is a crucial factor contributing to tubulointerstitial fibrosis in patients with IgA nephropathy (IgAN). However, the exact mechanisms by which Th17 cells induce tubulointerstitial fibrosis remain to be fully elucidated.
An IgAN mouse model was established and validated. Transcriptome sequencing, combined with bioinformatics analysis, was carried out to explore the immune injury pathways in renal tissues and the activation pathways in Th17 cells that were co-cultured with tubular epithelial cells. In subsequent experiments, small interfering RNA (siRNA) and overexpression plasmids were used to manipulate cellular targets. Validation was conducted through quantitative real-time polymerase chain reaction (qPCR), Western blotting, and immunofluorescence assays.
Compared with the control mice, IgAN mice exhibited elevated serum creatinine levels and increased urine protein-to-creatinine ratios. Renal pathological examination revealed the characteristic features of IgAN. Transcriptomic analysis of the kidney tissues from the model mice showed the activation of Th17 differentiation pathways, which was further confirmed by immunofluorescence analysis showing increased expression of interleukin-17A (IL-17A). These findings indicate an increased abundance of Th17 cells with potential pathogenic significance. When Th17 cells were co-cultured with tubular epithelial cells, the level of interleukin-9 (IL-9) in the system increased. This increase in IL-9 activated the Janus kinase 1-signal transducer and activator of transcription 3 (JAK1-STAT3) pathway through the IL-9 receptor (IL-9R) and upregulated the signature transcription factor retinoic acid-related orphan receptor gamma (ROR-γ), thus promoting Th17 cell differentiation. When IL-9R was silenced using siRNA or when the activity of STAT3 was inhibited, both the levels of phosphorylated STAT3 (p-STAT3) and ROR-γ decreased. Moreover, IL-17A secreted by Th17 cells promoted the nuclear translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in tubular epithelial cells by activating the IL-17 receptor A (IL-17RA)-adaptor protein Act1-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. This process regulated the production of inflammatory cytokines and drove the initiation and progression of fibrosis. Treatment with a STAT3 inhibitor in IgAN mice led to a reduction in the number of renal Th17 cells and alleviated the fibrotic phenotype.
This study demonstrated that the interaction between Th17 cells and tubular epithelial cells triggers excessive extracellular matrix deposition in the tubulointerstitium, thereby exacerbating the fibrotic phenotype and accelerating the progression of IgAN.
辅助性T细胞17(Th17)介导的免疫损伤是导致IgA肾病(IgAN)患者肾小管间质纤维化的关键因素。然而,Th17细胞诱导肾小管间质纤维化的确切机制仍有待充分阐明。
建立并验证IgAN小鼠模型。进行转录组测序并结合生物信息学分析,以探索肾组织中的免疫损伤途径以及与肾小管上皮细胞共培养的Th17细胞的激活途径。在后续实验中,使用小干扰RNA(siRNA)和过表达质粒来调控细胞靶点。通过定量实时聚合酶链反应(qPCR)、蛋白质免疫印迹法和免疫荧光测定法进行验证。
与对照小鼠相比,IgAN小鼠血清肌酐水平升高,尿蛋白与肌酐比值增加。肾脏病理检查显示出IgAN的特征性表现。对模型小鼠肾组织的转录组分析显示Th17分化途径激活,免疫荧光分析进一步证实白细胞介素-17A(IL-17A)表达增加。这些发现表明具有潜在致病意义的Th17细胞丰度增加。当Th17细胞与肾小管上皮细胞共培养时,体系中白细胞介素-9(IL-9)水平升高。IL-9的这种增加通过IL-9受体(IL-9R)激活Janus激酶1-信号转导子和转录激活子3(JAK1-STAT3)途径,并上调标志性转录因子视黄酸相关孤儿受体γ(ROR-γ),从而促进Th17细胞分化。当使用siRNA沉默IL-9R或抑制STAT3活性时,磷酸化STAT3(p-STAT3)和ROR-γ水平均降低。此外,Th17细胞分泌的IL-17A通过激活IL-17受体A(IL-17RA)-衔接蛋白Act1-肿瘤坏死因子受体相关因子6(TRAF6)复合物,促进肾小管上皮细胞中核因子κB(NF-κB)的核转位。这一过程调节炎症细胞因子的产生,并推动纤维化的起始和进展。用STAT3抑制剂治疗IgAN小鼠导致肾Th17细胞数量减少,并减轻纤维化表型。
本研究表明,Th17细胞与肾小管上皮细胞之间的相互作用触发肾小管间质中细胞外基质过度沉积,从而加剧纤维化表型并加速IgAN的进展。